Camrelizumab/apatinib vs. sorafenib as therapy for primary liver cancer: a retrospective study of a single Center
Dongbo Chen(Diponegoro University), Liyang Zhu(Huazhong Agricultural University), Yichun Wang(Anhui Medical University), Kang Mei(Anhui Medical University), Xiangxun Chen(Anhui Medical University)
Cited by 0
Related Papers
Mouse Embryonic Head as a Site for Hematopoietic Stem Cell Development
|Cell stem cell|2012|192
Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease
|Frontiers in Immunology|2022|122
G protein-coupled receptor 183 facilitates endothelial-to-hematopoietic transition via Notch1 inhibition
|Cell Research|2015|114
Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines
|Oncology Letters|2012|84
Rice grain yield and component responses to near 2°C of warming
|Field Crops Research|2014|82